210 related articles for article (PubMed ID: 32196659)
1. Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study.
Huang WK; Chang SH; Hsu HC; Chou WC; Yang TS; Chen JS; Chang JW; Lin YC; Kuo CF; See LC
Int J Cancer; 2020 Oct; 147(7):1904-1916. PubMed ID: 32196659
[TBL] [Abstract][Full Text] [Related]
2. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
3. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
4. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
5. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study.
Huang WW; Hsieh KP; Huang RY; Yang YH
Kaohsiung J Med Sci; 2017 Jun; 33(6):308-314. PubMed ID: 28601236
[TBL] [Abstract][Full Text] [Related]
7. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
9. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
10. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
11. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
Feng JL; Qin X
Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
[TBL] [Abstract][Full Text] [Related]
12. Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.
Cossor FI; Adams-Campbell LL; Chlebowski RT; Gunter MJ; Johnson K; Martell RE; McTiernan A; Simon MS; Rohan T; Wallace RB; Paulus JK
Cancer Epidemiol; 2013 Oct; 37(5):742-9. PubMed ID: 23773299
[TBL] [Abstract][Full Text] [Related]
13. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
16. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
Fransgaard T; Thygesen LC; Gögenur I
Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
[TBL] [Abstract][Full Text] [Related]
17. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
[TBL] [Abstract][Full Text] [Related]
18. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
20. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
